17 Ideal 'Safer' Buyable August Dogs Dug Up After 10 Years

I analyze 89 top Ten-Year Collected Dividend Dogs, focusing on yield-based strategies and safety via free cash flow coverage. Ten-year top dividend dogs project average net gains of 39.61% by August 2027, with risk profiles generally below market volatility. Seventeen 'safer' dogs meet the ideal of annual dividends from $1K invested exceeding share price, signaling strong income potential.

Seeking Alpha • Aug 28, 2026

LCUT vs. HLN: Which Stock Is the Better Value Option?

Investors interested in Consumer Products - Discretionary stocks are likely familiar with Lifetime Brands (LCUT) and Haleon PLC Sponsored ADR (HLN). But which of these two stocks presents investors with the better value opportunity right now?

Zacks Investment Research • Aug 26, 2026

Jefferies raises Haleon price target to 410p on margin strength

Jefferies has raised its price target for Haleon (Haleon PLC (LSE:HLN, NYSE:HLN), the consumer health company behind Sensodyne and Advil, to 410p from 400p, maintaining its Buy rating. The broker highlighted a 70 basis point margin beat in the first half of the year, though it warned this revived concerns about whether Haleon was investing enough behind growth.

Proactive Investors • Aug 24, 2026

Haleon plc: Announces Pricing Terms, Expiration and Results of its Cash Tender Offer for outstanding 2027 Notes

LONDON, Aug. 19, 2026 /PRNewswire/ -- Haleon plc (the "Company" or "Haleon") (LSE/NYSE: HLN) today announces the pricing terms, expiration and results of the offer to buy back any and all of the outstanding $1,999,350,000 3.375% Fixed Rate Senior Notes due March 2027 (the "Notes") of Haleon US Capital LLC's (the "Offeror"), the Company's wholly owned subsidiary (the "Tender Offer"). The Tender Offer has been made upon the terms and subject to the conditions set forth in the Offer to Purchase dated 11 August 2026 (the "Offer to Purchase").

PRNewsWire • Aug 19, 2026

Haleon plc: Cash tender offer for outstanding 2027 3.375% Fixed Rate Notes

LONDON, Aug. 11, 2026 /PRNewswire/ -- Haleon plc (the "Company" or "Haleon") (LSE/NYSE: HLN) today announces that its wholly owned subsidiary, Haleon US Capital LLC (the "Offeror") is offering to buy back any and all of its outstanding $1,999,350,000 3.375% Fixed Rate Senior Notes due March 2027. Bondholders will receive a price equal to the Total Consideration based on the Reference Yield and the Fixed Spread plus Accrued Interest (each as defined below) (the "Tender Offer").

PRNewsWire • Aug 11, 2026

Haleon plc (HLN) Q2 2026 Earnings Call Prepared Remarks Transcript

Haleon plc (HLN) Q2 2026 Earnings Call Prepared Remarks Transcript

Seeking Alpha • Aug 5, 2026

ACCO vs. HLN: Which Stock Is the Better Value Option?

Investors with an interest in Consumer Products - Discretionary stocks have likely encountered both Acco Brands (ACCO) and Haleon PLC Sponsored ADR (HLN). But which of these two companies is the best option for those looking for undervalued stocks?

Zacks Investment Research • Aug 4, 2026

Haleon slides as quality of growth questioned

Haleon PLC (LSE:HLN, NYSE:HLN) shares fell 2.9% to 368.7p after the consumer healthcare group reported improving second-quarter sales but left its full-year guidance unchanged. Organic revenue increased 3.1% in the second quarter, split between 1.7% from pricing and 1.4% from volumes and product mix.

Proactive Investors • Jul 30, 2026

Haleon plc (HLN) Q2 2026 Earnings Call Transcript

Haleon plc (HLN) Q2 2026 Earnings Call Transcript

Seeking Alpha • Jul 30, 2026

Sensodyne maker Haleon posts higher second-quarter organic revenue growth

British consumer ​health company Haleon ‌reported second-quarter organic ​sales ​growth of 3.1% ⁠on ​Thursday, in ​line with market expectations, driven ​by ​strong demand for ‌its ⁠oral health products and accelerating ​growth ​in ⁠North America, ​its largest ​market.

Reuters • Jul 30, 2026